Long-term outcome of a phase III trial on neoadjuvant chemoradiation with capecitabine and irinotecan in patients with locally advanced rectal cancer: Updated results of the CinClare trial.

Authors

null

Ji Zhu

Fudan University Cancer Center, Shanghai, China

Ji Zhu , Xinchen Sun , Anwen Liu , Yaqun Zhu , Tao Zhang , Luying Liu , Jianhui Jia , Shisheng Tan , Junxin Wu , Xin Wang , Juying Zhou , Jialin Yang , Chen Zhang , Hongyan Zhang , Xinjia He , Gang Cai , Wei Zhang , Sanjun Cai , Zhen Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT02605265

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3603)

DOI

10.1200/JCO.2021.39.15_suppl.3603

Abstract #

3603

Poster Bd #

Online Only

Abstract Disclosures